This module will provide you with training in the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
RACGP for 2 (category 2) pointsToggle information
This activity has been approved for 2 (Category 2) points in the RACGP QI & CPD Program for the 2017 - 2019 triennium (activity number 91676).
ACRRM for 1 core pointToggle information
This activity has been accredited for 1 core points in the ACRRM PD Program for the 2017 - 2019 triennium (activity code: 7261).
- Recognised for the Practice Incentives Program Quality Prescribing Incentive (PIP QPI)
This online learning module will update and enhance your skills in the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
Hepatitis C (HCV) remains a significant public health issue in Australia and GPs are an essential part of the management team, from identifying people who may be at risk of infection to diagnosis and monitoring of liver disease.
In addition, with the new direct-acting antiviral (DAA) agents now available on the PBS general schedule it is even more vital that GPs are aware of HCV treatment strategies.
After completing this learning module, you will be able to:
- describe the characteristics that determine whether a patient is a member of a vulnerable group and are therefore considered high risk for hepatitis C infection
- identify the most appropriate ways to open a discussion with patients about HCV and describe the treatment options for patients and the GPs role in management
- explain what is required of a GP to diagnose hepatitis C and what investigations need to be completed to determine treatment course
- explain what is required to evaluate underlying liver disease and describe factors which may progress liver disease in a patient with HCV infection
- implement a recall system to monitor patients during treatment and for long term monitoring following treatment completion.